Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 2016

View Archived Issues

Arbutus initiates phase IIa study of ARB-001467 for chronic HBV

MedImmune initiates phase II trial of MEDI-6012 in coronary artery disease

Matinas BioPharma files IND application with FDA for MAT-2501

Fibrocell and Intrexon to address chronic inflammatory and degenerative diseases of the joint

Enrollment complete in phase I trial of AVXS-101 in spinal muscular atrophy type 1

Novel muscarinic receptor modulator demonstrates a positive profile in vivo and in vitro

Roche starts phase I trial of spinal muscular atrophy candidate RO-7034067

Merck KGaA, Pfizer and Syndax to evaluate avelumab and entinostat in ovarian cancer

Baxalta and Symphogen form immuno-oncology collaboration

Merck & Co. patents nAChR alpha7 PAMs

Yuma Therapeutics and The Brigham and Women's Hospital develop HSP90 inhibitors

Emulate develops Small Airway Lung-Chip

KineMed and Pfizer establish biomarker discovery collaboration

Additional gene variants identified for AMD

Yisheng Biopharma releases phase I topline results for PIKA rabies vaccine

Higher doses of laquinimod discontinued in two MS trials following cardiovascular events

Simoctocog alfa now available in U.S.

FDA grants priority review to Gilead's NDA for sofosbuvir/velpatasvir

Sprouty has an atypical role as an oncogene in colorectal cancer

University of Virginia's artificial pancreas technology to enter pivotal trials in type 1 diabetes

Panasonic Healthcare completes acquisition of Bayer AG's Diabetes Care business

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...